# Safety and Efficacy of IDA for Onchocerciasis

> **NCT04188301** · PHASE2 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 154 (actual)

## Conditions studied

- Onchocerciasis

## Interventions

- **DRUG:** IVM w/ ALB
- **DRUG:** Single dose of IDA
- **DRUG:** Three daily doses of IDA

## Key facts

- **NCT ID:** NCT04188301
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-06
- **Primary completion:** 2022-03-14
- **Final completion:** 2022-06-01
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2024-06-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04188301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04188301, "Safety and Efficacy of IDA for Onchocerciasis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04188301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*